Carbidopa



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Parkinson's Disease 89.5%
Dystonia 10.5%
Aggression 14.3%
Bursitis 14.3%
Dopamine Dysregulation Syndrome 14.3%
Drug Abuse 14.3%
Neuroleptic Malignant Syndrome 14.3%
Osteoarthritis 14.3%
Tremor 14.3%
Secondary
Parkinson's Disease 46.0%
Psychotic Disorder 26.3%
Drug Use For Unknown Indication 12.9%
Parkinsonism 6.7%
Dystonia 0.9%
Insomnia 0.9%
Prophylaxis 0.9%
Psychiatric Symptom 0.9%
Restless Legs Syndrome 0.9%
Anxiety Disorder 0.4%
Blood Pressure 0.4%
Constipation 0.4%
Dermatitis Atopic 0.4%
Gastrooesophageal Reflux Disease 0.4%
Infection 0.4%
Pain In Extremity 0.4%
Thyroid Disorder 0.4%
Drug Ineffective 14.3%
No Adverse Event 11.4%
Subileus 11.4%
Coronary Artery Disease 5.7%
Headache 5.7%
Neuroleptic Malignant Syndrome 5.7%
Urinary Retention 5.7%
Weight Decreased 5.7%
Drug Interaction 2.9%
Gait Disturbance 2.9%
Ileus 2.9%
Muscle Rigidity 2.9%
Muscular Weakness 2.9%
Parkinson's Disease 2.9%
Pathological Gambling 2.9%
Pharyngitis 2.9%
Psychiatric Symptom 2.9%
Somnolence 2.9%
Therapeutic Response Unexpected 2.9%
Torticollis 2.9%
Concomitant
Parkinson's Disease 28.3%
Product Used For Unknown Indication 26.3%
Drug Use For Unknown Indication 10.9%
Pain 5.6%
Hypertension 3.0%
Depression 2.6%
Metastases To Bone 2.5%
Ill-defined Disorder 2.4%
Osteoporosis 2.3%
Restless Legs Syndrome 2.1%
Breast Cancer 1.7%
Rheumatoid Arthritis 1.6%
Bone Lesion 1.5%
Diabetes Mellitus 1.5%
Multiple Myeloma 1.5%
Chronic Obstructive Pulmonary Disease 1.4%
Chemotherapy 1.2%
Muscle Spasms 1.2%
Arthritis 1.1%
Insomnia 1.1%
Wheezing 10.8%
Death 10.3%
Wrong Drug Administered 8.9%
Parkinson's Disease 7.9%
Tremor 7.9%
Vomiting 6.9%
Weight Increased 4.9%
Drug Ineffective 4.4%
Fall 4.4%
Nausea 3.9%
Transient Ischaemic Attack 3.9%
Hypotension 3.4%
Medication Error 3.4%
Insomnia 3.0%
Pain 3.0%
Tooth Extraction 3.0%
Myocardial Infarction 2.5%
Pneumonia 2.5%
Serotonin Syndrome 2.5%
Vertigo 2.5%
Interacting
Parkinson's Disease 69.2%
Diabetic Neuropathy 15.4%
Neuralgia 15.4%
Drug Interaction 66.7%
Respiratory Depression 33.3%